Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2002
Report date:
2002

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
Deviations:
no
GLP compliance:
yes
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
441-070-6
EC Name:
-
Cas Number:
61826-76-4
Molecular formula:
C14H11NO2
IUPAC Name:
(2S)-2-hydroxy-2-(3-phenoxyphenyl)acetonitrile

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
corn oil
Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
The preparations of the test substance were made freashly every day shortly before the administration to the animals. The dosing volume was 1 mL/kg bw
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
28 days
Frequency of treatment:
once a day, 7 days/week
Doses / concentrationsopen allclose all
Dose / conc.:
0 mg/kg bw/day (nominal)
Remarks:
Negative control
Dose / conc.:
5 mg/kg bw/day (nominal)
Remarks:
Low dose
Dose / conc.:
16 mg/kg bw/day (nominal)
Remarks:
Mid dose
Dose / conc.:
50 mg/kg bw/day (nominal)
Remarks:
High dose
No. of animals per sex per dose:
5
Control animals:
yes
Details on study design:
- Dose selection rationale: the selection of the doses was based on the results of a dose range finding study.
Positive control:
N.A.

Results and discussion

Results of examinations

Details on results:
- Mortality:
There was no test substance related mortality
- Observations in life, clinical and functional observations:
In high dosed animals, "digging in the bedding material", a sign, indicating unpleasant sensations, was noted frequently after test substance administration
- Body weights and feed consumption:
In the third week of dosing, feed consumption of high dosed females was statistically significantly lower than in the controls. Except for this, no significant differences were noted in body weights and feed consumption
- Hematology and clinical chemistry:
There were no statistically significant differences between a dosed group and the controls
- Organ weights
Liver and spleen were statistically significantly increased in high dose females
- Necropsy
There were no test substance related alterations noted
- Recovery groups
There were no test substance related alterations until the end of the recovery group

Effect levels

Key result
Dose descriptor:
NOEL
Effect level:
16 mg/kg bw/day (nominal)
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: Organ weights

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
In an oral short-term repeated dose toxicity study conducted according to OECD guideline 407, rats were treated with 5, 16 and 50 mg/kg bw/day once a day, 7 days per week for a total of 28 days. Based on the results, the NOEL can be considered to be 16 mg/kg bw/day.
Executive summary:

In an oral short-term repeated dose toxicity study conducted according to OECD guideline 407, rats were treated with 5, 16 and 50 mg/kg bw/day once a day, 7 days per week for a total of 28 days. Based on the results, the NOEL can be considered to be 16 mg/kg bw/day. No classification is warranted according to CLP regulation 1272/2008.